Advertisement
Australia markets close in 3 hours 54 minutes

  • ALL ORDS

    7,841.90
    -95.60 (-1.20%)
     

  • ASX 200

    7,580.30
    -102.70 (-1.34%)
     

  • AUD/USD

    0.6533
    +0.0010 (+0.15%)
     

  • OIL

    83.80
    +0.23 (+0.28%)
     

  • GOLD

    2,344.70
    +2.20 (+0.09%)
     

  • Bitcoin AUD

    98,826.70
    +508.99 (+0.52%)
     

  • CMC Crypto 200

    1,391.11
    +8.53 (+0.62%)
     

  • AUD/EUR

    0.6086
    +0.0013 (+0.21%)
     

  • AUD/NZD

    1.0945
    -0.0013 (-0.11%)
     

  • NZX 50

    11,863.17
    -83.26 (-0.70%)
     

  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     

  • DAX

    17,917.28
    -171.42 (-0.95%)
     

  • Hang Seng

    17,545.49
    +260.95 (+1.51%)
     

  • NIKKEI 225

    37,789.47
    +160.99 (+0.43%)
     

Invitae to Announce First Quarter 2023 Financial Results on Tuesday, May 9, 2023

PR Newswire
·2-min read

SAN FRANCISCO, April 26, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it will report its first quarter 2023 financial results on Tuesday, May 9, 2023, and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights.

Invitae's (NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. www.invitae.com (PRNewsFoto/Invitae Corporation)
Invitae's (NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. www.invitae.com (PRNewsFoto/Invitae Corporation)

To access the conference call, please register at the link below:
https://www.netroadshow.com/events/login?show=cd3e99e2&confId=49697

Upon registering, each participant will be provided with call details and access codes.

The live webcast of the call and slide deck may be accessed here or by visiting the investors section of the company's website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website.

ADVERTISEMENT

About Invitae
Invitae (NYSE: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information simplified by digital technology. With accurate and actionable answers to strengthen medical decision-making, Invitae gives individuals and their families powerful, personalized insights that could improve and extend their lives. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.

To learn more, visit invitae.com and follow for updates on Twitter, Instagram, Facebook and LinkedIn @Invitae.

Invitae Contacts:

Investor Relations
Hoki Luk
ir@invitae.com

Public Relations
Amy Hadsock
pr@invitae.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/invitae-to-announce-first-quarter-2023-financial-results-on-tuesday-may-9-2023-301807621.html

SOURCE Invitae Corporation